Pfizer might slash R&D funding after Wyeth buyout:

10/16/2009 | Bloomberg · Wall Street Journal, The

Pfizer might trim its research funding by as much as $3 billion when it consolidates laboratories with Wyeth after their merger. Martin Mackay, president of Pfizer Global Research and Development, did not disclose the exact amount of the budget cut, which is part of a restructuring that also includes eliminating about 15% of the companies' combined workforce.

View Full Article in:

Bloomberg · Wall Street Journal, The